GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Formosa Laboratories Inc (TPE:4746) » Definitions » Beneish M-Score

Formosa Laboratories (TPE:4746) Beneish M-Score : -2.55 (As of Mar. 27, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Formosa Laboratories Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.55 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Formosa Laboratories's Beneish M-Score or its related term are showing as below:

TPE:4746' s Beneish M-Score Range Over the Past 10 Years
Min: -2.89   Med: -2.6   Max: -1.83
Current: -2.55

During the past 13 years, the highest Beneish M-Score of Formosa Laboratories was -1.83. The lowest was -2.89. And the median was -2.60.


Formosa Laboratories Beneish M-Score Historical Data

The historical data trend for Formosa Laboratories's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Laboratories Beneish M-Score Chart

Formosa Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.62 -1.83 -2.58 -2.67 -2.55

Formosa Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.67 -2.72 -2.68 -2.65 -2.55

Competitive Comparison of Formosa Laboratories's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Formosa Laboratories's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Laboratories's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Formosa Laboratories's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Formosa Laboratories's Beneish M-Score falls into.


';

Formosa Laboratories Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Formosa Laboratories for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1307+0.528 * 1.0186+0.404 * 0.7695+0.892 * 1.085+0.115 * 0.9861
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0692+4.679 * -0.040954-0.327 * 0.946
=-2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was NT$1,255 Mil.
Revenue was 1351.546 + 1030.885 + 1214.512 + 1134.103 = NT$4,731 Mil.
Gross Profit was 559.686 + 424.16 + 522.8 + 542.07 = NT$2,049 Mil.
Total Current Assets was NT$5,868 Mil.
Total Assets was NT$13,895 Mil.
Property, Plant and Equipment(Net PPE) was NT$6,204 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$507 Mil.
Selling, General, & Admin. Expense(SGA) was NT$502 Mil.
Total Current Liabilities was NT$2,356 Mil.
Long-Term Debt & Capital Lease Obligation was NT$2,752 Mil.
Net Income was -53.013 + 22.371 + 283.929 + -96.019 = NT$157 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 282.204 + 283.932 + -98.329 + 258.527 = NT$726 Mil.
Total Receivables was NT$1,023 Mil.
Revenue was 1212.319 + 1129.226 + 1086.934 + 931.969 = NT$4,360 Mil.
Gross Profit was 525.961 + 486.961 + 498.613 + 411.794 = NT$1,923 Mil.
Total Current Assets was NT$5,244 Mil.
Total Assets was NT$13,636 Mil.
Property, Plant and Equipment(Net PPE) was NT$6,068 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$488 Mil.
Selling, General, & Admin. Expense(SGA) was NT$433 Mil.
Total Current Liabilities was NT$3,241 Mil.
Long-Term Debt & Capital Lease Obligation was NT$2,057 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1255.468 / 4731.046) / (1023.362 / 4360.448)
=0.265368 / 0.234692
=1.1307

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1923.329 / 4360.448) / (2048.716 / 4731.046)
=0.441085 / 0.433037
=1.0186

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5868.02 + 6204.403) / 13895.381) / (1 - (5243.666 + 6067.676) / 13636.191)
=0.131192 / 0.170491
=0.7695

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4731.046 / 4360.448
=1.085

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(488.329 / (488.329 + 6067.676)) / (506.932 / (506.932 + 6204.403))
=0.074486 / 0.075534
=0.9861

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(502.255 / 4731.046) / (432.945 / 4360.448)
=0.106162 / 0.099289
=1.0692

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2752.16 + 2355.793) / 13895.381) / ((2057.288 + 3241.391) / 13636.191)
=0.367601 / 0.388575
=0.946

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(157.268 - 0 - 726.334) / 13895.381
=-0.040954

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Formosa Laboratories has a M-score of -2.55 suggests that the company is unlikely to be a manipulator.


Formosa Laboratories Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Formosa Laboratories's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Formosa Laboratories Business Description

Traded in Other Exchanges
N/A
Address
No. 36-1, Hoping Street, Louchu, Taoyuan, TWN, 33842
Formosa Laboratories Inc is mainly engaged in the wholesale and manufacturing of active pharmaceutical ingredients, as well as ultraviolet absorbers. The company geographically operates in India, Taiwan, Netherlands, Switzerland, Germany, Japan, China, Canada, United States, Spain and Others.

Formosa Laboratories Headlines

No Headlines